Literature DB >> 23254259

[Orbital neoplasia. Part II: mesenchymal, leukemic, lymphoproliferative and bony tumors, metastasis].

M P Schittkowski1, N Fichter.   

Abstract

With reference to the first article on the topic orbital neoplasias this second part focuses on the main characteristics of mesenchymal, leukemic, lymphoproliferative, osseous as well as secondary neoplasias of the orbit. For each entity the therapeutic approaches are presented. A large number of case report examples underline once more the importance of an efficient diagnostic procedure to ensure sufficient treatment of the lesion itself as well as the relatively common underlying systemic disease.

Entities:  

Mesh:

Year:  2013        PMID: 23254259     DOI: 10.1007/s00347-012-2740-7

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  16 in total

1.  Cancer metastatic to the orbit: the 2000 Robert M. Curts Lecture.

Authors:  J A Shields; C L Shields; H K Brotman; C Carvalho; N Perez; R C Eagle
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2001-09       Impact factor: 1.746

2.  Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit.

Authors:  Guy J Ben Simon; Ning Cheung; Penny McKelvie; Richard Fox; Alan A McNab
Journal:  Ophthalmology       Date:  2006-04-27       Impact factor: 12.079

3.  The incidence of ocular metastatic carcinoma.

Authors:  R S Bloch; S Gartner
Journal:  Arch Ophthalmol       Date:  1971-06

Review 4.  [Orbital neoplasia. Part I: Introduction, vascular and neurogenic tumors].

Authors:  M P Schittkowski; N Fichter
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

Review 5.  Intravenous and intra-arterial chemotherapy for retinoblastoma: what have we learned?

Authors:  Carol L Shields; Swathi Kaliki; Duangnate Rojanaporn; Saad Al-Dahmash; Carlos G Bianciotto; Jerry A Shields
Journal:  Curr Opin Ophthalmol       Date:  2012-05       Impact factor: 3.761

6.  Malignant tumors of the orbit. Analysis of the Florida Cancer Registry.

Authors:  C E Margo; Z D Mulla
Journal:  Ophthalmology       Date:  1998-01       Impact factor: 12.079

7.  Clinical and radiological presentation of 95 orbital lymphoid tumors.

Authors:  E Polito; P Galieni; A Leccisotti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

8.  Fibrous histiocytoma of the orbit. A clinicopathologic study of 150 cases.

Authors:  R L Font; A A Hidayat
Journal:  Hum Pathol       Date:  1982-03       Impact factor: 3.466

9.  Orbital and ocular manifestations of acute childhood leukemia: clinical and statistical analysis of 180 patients.

Authors:  V Russo; I U Scott; G Querques; A Stella; A Barone; N Delle Noci
Journal:  Eur J Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 2.597

Review 10.  Ocular and orbital involvement in leukemia.

Authors:  M C Kincaid; W R Green
Journal:  Surv Ophthalmol       Date:  1983 Jan-Feb       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.